[125]
The prior art references relied upon by Apotex demonstrate the limited knowledge available to a skilled person in June 1985 about the chirality of quinolones. None of the Ofloxacin references, Flumequine references or Other references, either alone or in combination, would have led a skilled person directly and without difficulty to the invention disclosed in the '080 patent, thus, levofloxacin and its unexpected beneficial properties.
Climate in the relevant field and motivation at the time of the alleged invention
(a) Racemic fluoroquinolones were not resolved